Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study). (2019)
Attributed to:
Centre for Drug Safety Science (CDSS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.pmed.1002895
PubMed Identifier: 31539371
Publication URI: http://europepmc.org/abstract/MED/31539371
Type: Journal Article/Review
Volume: 16
Parent Publication: PLoS medicine
Issue: 9
ISSN: 1549-1277